Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients | TheHill - The Hill

1. Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients | TheHill  The Hill
2. Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients  The Wall Street Journal
3. 2nd study testing a COVID-19 antibody drug has a setback  Yahoo News
4. Covid toes could last for 150 days, new research finds  NBC News
5. Could your smartwatch help detect the next COVID-19 outbreak? San Diego scientists think so  The San Diego Union-Tribune
6. View Full Coverage on Google News

via Top stories - Google News https://ift.tt/3oGYoMe